positive
Recently
NephroPlus gains SEBI clearance for ₹353 crore IPO to expand dialysis network
NephroPlus received SEBI approval for a ₹353 crore IPO to expand dialysis centers and modernize technology across India and international markets.
Healthcare services provider NephroPlus secured SEBI approval to raise ₹353 crore through an initial public offering aimed at expanding its dialysis center network across India and international markets. Proceeds will fund new centers in Tier-2 cities and support technology upgrades in clinical operations. The Hyderabad-based company currently manages over 300 dialysis centers and serves 22,000 patients monthly.
The IPO is expected to enhance liquidity and deepen NephroPlus’s presence in the specialty healthcare segment amid rising chronic kidney disease burden globally.